semaglutide itchy skin on Wegovy? What it means and what to do Everything You Need to Know

Patients with personal or familial histories of certain cancers, endocrine disorders, or significant gastrointestinal diseases should discuss alternatives with their provider

At this time, Wegovy is the only weight-loss medication approved for cardiovascular risk (heart attack, stroke and cardiovascular death)

The fundamental difference between these medications lies in their mechanism of action: This dual-action approach is why Mounjaro consistently outperforms Wegovy in clinical trials

Some preclinical studies suggest BPC-157 may work with physical therapy, platelet-rich plasma (PRP), or growth factors, but combination studies in humans are still lacking

The answer depends on several variables